----item----
version: 1
id: {3C807909-C35D-42AC-B8AF-A8C9D7907EE4}
database: master
path: /sitecore/content/ScripIntelligence/Home/Articles/2015/05/08/INFOGRAPHIC Biomarkers in clinical trials 2015
parent: {1161A4EF-B60F-4225-ADC5-090F8BB00FAF}
name: INFOGRAPHIC Biomarkers in clinical trials 2015
master: {00000000-0000-0000-0000-000000000000}
template: {11380B5D-3531-4570-B213-EFC5312266E4}
templatekey: Article

----version----
language: en
version: 1
revision: bcd051dc-c416-4ddf-9056-ce45c697313e

----field----
field: {2D750EFF-9058-4ABF-A7FF-57FFE5DA1E3C}
name: Title
key: title
content-length: 50

 INFOGRAPHIC: Biomarkers in clinical trials 2015  
----field----
field: {F1D1DC93-63DF-4AFA-B60F-B3A3E9D36675}
name: Sub Title
key: sub title
content-length: 46

INFOGRAPHIC Biomarkers in clinical trials 2015
----field----
field: {446A339B-E1D9-4DE1-8B5E-DB7942EF1723}
name: Body
key: body
content-length: 1386

<p> The number of clinical trials using biomarkers has increased over the past 12 months, particularly in the area of oncology, according to latest figures from Citeline. </p> <p> This infographic, based on Citeline's most recent figures, shows breast cancer remains the largest indication for stratified trials, but also popular were non-small cell lung and colorectal cancers, and non-Hodgkin lymphoma. </p> <p> This is an update on a previous <a href="http://www.scripintelligence.com/home/INFOGRAPHIC-The-rise-of-the-pharmacogenomic-biomarker-in-clinical-trials-351437" target="_new">infographic</a> published last year, based on a whitepaper by Citeline and produced in association with <i>Scrip</i>'s sister publication <i>Clinica Medtech Intelligence</i>. </p> <p> <a target="_blank" href="http://www.scripintelligence.com/multimedia/archive/00249/BIOMARKER_2015_R2_249728a.gif"><img src="-/media/4D0F035569D1482FBEF2B4030AAA5A42.ashx"> </a> </p> <p> For full details of the original whitepaper, <i>Recent Trends in Personalized Medicine: Increasing Clinical Use and Impact of Pharmacogenomic and Epigenetic Biomarkers in Oncology</i> by Fern Barkalow PhD, go to <a target="_new" href="https://citeline.com/wp-content/uploads/March-2014_Epigenetic-Biomarkers_Fern-Barkalow.pdf">https://citeline.com/wp-content/uploads/March-2014_Epigenetic-Biomarkers_Fern-Barkalow.pdf </a> </p> 
----field----
field: {5BA0578F-65B7-4C22-8233-1603D698D8A4}
name: Summary
key: summary
content-length: 175

<p> The number of clinical trials using biomarkers has increased over the past 12 months, particularly in the area of oncology, according to latest figures from Citeline. </p>
----field----
field: {8F4EE718-6FA0-42A5-85C4-6C8FE8B1FCD4}
name: Navigation Title
key: navigation title
content-length: 46

INFOGRAPHIC Biomarkers in clinical trials 2015
----field----
field: {7C4FC796-1311-4DAA-81AC-85EAA2C1C108}
name: Actual Publish Date
key: actual publish date
content-length: 15

20150508T144749
----field----
field: {BDF7C8E1-869E-49FF-B9F5-854B3081A45D}
name: Created Date
key: created date
content-length: 15

20150508T144749
----field----
field: {C926A72A-39DA-446D-B78C-2A650F820A73}
name: Modified Date
key: modified date
content-length: 15

20150508T144749
----field----
field: {1616FE67-7278-4169-948E-C29B00EC8781}
name: Article Number
key: article number
content-length: 8

SC028663
----field----
field: {31603F25-6D9C-4954-BCDE-342E1E184A30}
name: Meta Title Override
key: meta title override
content-length: 50

 INFOGRAPHIC: Biomarkers in clinical trials 2015  
----field----
field: {5AD65E47-7554-4CE5-87B0-7FB65051C05A}
name: Authors
key: authors
content-length: 38

{D076E7AE-4BEB-4E57-97DF-8F97A3651301}
----field----
field: {0F6C8F42-01DC-4E05-B63E-AA25D8AA0E09}
name: Legacy Publication
key: legacy publication
content-length: 38

{0F9CCE10-91C1-4F31-832A-266F482A5DAF}
----field----
field: {5795FF15-0942-41FF-8A77-3B73185F5E1B}
name: Escenic ID
key: escenic id
content-length: 6

358175
----field----
field: {25BED78C-4957-4165-998A-CA1B52F67497}
name: __Created
key: __created
content-length: 16

20160209T042340Z
----field----
field: {5DD74568-4D4B-44C1-B513-0AF5F4CDA34F}
name: __Created by
key: __created by
content-length: 18

sitecore\Anonymous
----field----
field: {8CDC337E-A112-42FB-BBB4-4143751E123F}
name: __Revision
key: __revision
content-length: 36

bcd051dc-c416-4ddf-9056-ce45c697313e
----field----
field: {D9CF14B1-FA16-4BA6-9288-E8A174D4D522}
name: __Updated
key: __updated
content-length: 16

20160209T042342Z
----field----
field: {BADD9CF9-53E0-4D0C-BCC0-2D784C282F6A}
name: __Updated by
key: __updated by
content-length: 18

sitecore\Anonymous
